Used primarily in research settings as a psychoactive substance, this compound interacts with central nervous system receptors, particularly serotonin and dopamine pathways. It has been identified as an active ingredient in some synthetic cannabinoids, where it acts as a core structure to enhance binding affinity to cannabinoid receptors. Due to its structural properties, it is studied for its potential effects on neurotransmitter release and receptor modulation. However, it is not used in clinical medicine and is mainly encountered in forensic and analytical research to understand designer drug metabolism and toxicity. Its presence is often monitored in drug screening programs due to association with recreational drug use and potential health risks.